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THE ROLE OF SULFATIDE IN ALZHEIMER'S DISEASE 
By Charles Britton Beasley, Jr., B.S. Biology 
A Thesis submitted in partial fulfillment of the requirements for the degree of Master's in 
Anatomy and Neurobiology at Virginia Conmonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Jeffrey Dupree, Ph.D. 
Assistant Professor, Department of Anatomy and Neurobiology 
Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta 
plaques, neurofibrillary tangles (NFT) and loss of cortical neurons that control memory 
and cognition. The cause of NFTs and AP plaques is not clear, though it is known that they 
are formed by enzymes which are preferentially sequestered to membrane domains called 
lipid rafts. Sulfatide (ST) is a glycosphingolipid that is essential for the proper structure 
and function of lipid rafts. In mice that lack ST, membrane domains that are normally 
maintained by adhesive contacts and functional lipid rafts are improperly formed and are 
unstable. In these ST null mice, voltage gated sodium channels, neuronal proteins that 
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normally cluster at the nodes of Ranvier, initially accumulate in the node but are not 
retained with age. Taken together the findings from the ST null mice indicate that 
membrane organization is compromised. Recently, a published report demonstrated that 
ST is significantly reduced in AD. Based on this observation combined with the findings 
Erom the ST null mice, I propose that membrane architecture is also altered in AD and this 
alteration may facilitate AD pathogenesis. To test this hypothesis, I have used an 
imrnunohistochemical approach to assess neuronal membrane organization in AD and non- 
AD brain samples. Analysis of the sodium channel clusters was chosen since these nodal 
domains provide an easy assessment tool for membrane organization. In the current study, 
sodium channel domains were not altered and no change in isoform expression was 
observed. Based on these fmdings, membrane organization does not appear to be altered in 
AD. It is important to note, however, that sodium channel clusters are restricted to a 
specific region of the axon and thus membrane organization within other regions of the 
axon and in other regions of the neuron may be altered. Additionally, assessment of the 
brain samples, using thin layer chromatography, did not show a reduction in ST levels 
between the AD and non-AD brains. Therefore, my study strongly suggests that M e r  
analysis of ST levels in AD brains sould be conducted to resolve the contrasting results 
between the current study and the previously published work. 
Introduction 
Overview of Alzheimer's Disease 
Alzheimer's disease (AD) is the most prevalent cause of neural degeneration and 
dementia in the rapidly growing elderly population. Patients with AD experience mild to 
severe dementia including progressive memory loss. Though the trends resemble those of 
the normal aging brain, symptoms are significantly exaggerated in AD. Age is the most 
important risk factor. The characteristic pathologies at the microscopic level are arnyloid 
beta (AP) plaques and neurofibrillary tangles (NFT). Though these are well-established 
indicators, much remains to be understood about their formation. (reviewed by Armstrong, 
2006). 
Diagnosis of AD involves both psychological analysis for the presence and level of 
dementia and post-mortem morphological testing for AP plaques and NFTs. The rnini- 
mental state examination (MMSE) and the AD assessment scale (ADAS) are both used as 
objective measures of progression of cognitive impairment (Schmitt et al., 2002). In 
addition to the MMSE and ADAS classifications, Braak and Braak (1 991) developed a 
staging system for the disease that is based on the degree and location of NFTs. Braak and 
Braak demonstrated that levels of AD correlated with the patterns and extent of NFT 
formation. In this system, stages I and I1 are characterized by mild to severe alteration of 
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the transentorhinal layer; stages I11 and IV involve the proper entorhinal cortex, and stages 
V and VI show destruction of isocortical association areas as well. Magnetic resonance 
imaging for loss of gray and white matter is also used in the diagnosis (Karas et al., 2004; 
Sjobeck et al., 2006). 
AD can be divided into familial and non-familial categories. Familial AD is 
usually associated with early onset and often involves mutations in the APP gene or 
presenilins. Gottries et al., (1 996) used confusional symptomatology and parietal 
pathology to differentiate between the two categories. Parietal pathology was associated 
more with the early AD and confusioanl symptomatology with late onset. 
The cause of Alzheimer's remains unknown. Various treatments including 
acetylchoinesterase (AChE) inhibitors and new experimental therapies using AP antibodies 
have been used with minimal success. AChE has been very effective in providing 
incremental increase in cognitive ability by increasing levels of acetylcholine, but has no 
effect on the underlying pathology. The use of antibodies is still under examination. 
Histopathology of Alzheimer's Disease 
The underlying cause of dementia in AD is loss of neurons. Specifically, this loss 
is seen in pyramidal and interneurons in the entorhinal neocortices, the nucleus basalis, 
basal forebrain, and pyramidal neurons in the CAI and CA2 regions of the hippocampus. 
This loss of cells leads to gross brain changes such as reduction in overall brain size, 
widened sulci, narrowed gyri, and dilated ventricles. Microscopic analysis using silver 
stains reveals the two hallmark pathologies that are NFTs and AP plaques (Figure 1). 
NFTs are found intracellularly and AP plaques extracellularly (DeArmond, 1997). 
NFTs are not unique to AD, although they are a necessary histological finding for 
AD diagnosis (Braak and Braak, 1991). They are also found in Parkinson's and 
amyotrophic lateral sclerosis (Kokubo and Kuzuhara, 2004). Tangles are formed in 
neuronal cell bodies as a result of hyperphosphorylation of the microtubule associated 
protein tau. Hyperphosphorylation of tau results in the formation of paired helical 
filaments (PHF), which are the building blocks of NFTs. Microtubule associated protein 
kinase, glycogen synthase kinase-3, cyclin-dependant kinase 2, cyclin-dependant kinase 5, 
calcium/calmodulin-dependent protein kinase 11, protein kinase A, and fyn kinase have 
been shown to be involved in this hyperactive phosphorylation (Drewes et al., 1992; 
Madelkow et al., 1992; Baumann et al., 1993). Fyn and cdk are associated with lipid rafts 
as well (Kramer et al., 1999). Reduced phosphatase activity has also been reported in AD 
and implicated in the formation of tangles (Matsuo et al., 1994; Iqbal et al., 1994). Though 
tau is normally phosphorylated only at sites outside the microtubule (MT) binding region, 
in PHFs phosphorylation is found at sites within .the MT binding region (De Armond, 
1997).When abnormally phosphorylated, tau does not bind properly to MTs, but rather 
associates with itself (De Armond, 1997). 
Figure 1: Hallmark histopathologies in Alzheimer's disease: neurofibrillary tangles and 
arnyloid beta plaques. (Taken from American Health Assistance Foundation: 
http://www.ahaf.org/alzdis/about/AmyloidPlaques.htm) 
Figure 1: Illustration of neurofibrillary tangles and amyloid beta plaques 
The theoretical course then, by which NFTs prove toxic to neurons consists of the 
following steps as described by Trojanowski and Lee, (2005): First, the abnormal 
hyperphosphorylation of tau leads to tau aggreagation. This leads to a decrease in MT- 
bound tau and then to MT depolymerization. Axonal transport is impaired as a result, and 
leads to stasis and aggregation of axonal traffic. Function at the synapse is compromised 
and axons degenerate and disconnect. 
As mentioned above, AP plaques are the other of the classic neuropathologic 
hallmarks of AD and are also required for AD diagnosis. These plaques are the product of 
an alternate cleavage of the type I transmembrane protein, amyloid precursor protein 
(APP) (Figure 2). APP is ubiquitously expressed protein whose function remains unclear. 
There are two types of APP cleavage, alpha-gamma and beta-gamma, both of which occur 
on the ltunenal side of membranes (Greenfield et al., 1999). The alpha-gamma cleavage 
(non-amyloidogenic) consists of a cut at the alpha site by alpha-secretases, which occurs at 
the cell membrane. Several zinc metaloproteinases and the aspartyl proteinase beta- 
amyloid cleavage enzyme 2, that are present mostly at the cell surface, are responsible for 
the cut at the alpha site. This cleavage is followed by another cut at the gamma site within 
the transmembrane domain of APP by the multimaic protein complex known as the 
gamma secretase. The gamma cleavage occurs mainly in endocytotic vesicles The alpha- 
gamma sequence is the normal non-pathologic event that occurs 95% of the time. 
In AD, the beta-gamma (amyloidogenic) sequence becomes more prevalent, 
resulting in the deposit of the toxic AP peptides (Vetrivel and Thinakaran, 2006). In this 
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pathologic state, the alpha cleavage is replaced by a beta-cleavage occuring mainly on the 
membrane of endocytotic vesicles by the membrane bound beta-amyloid cleavage enzyme 
1 (BACE 1 or just BACE). AP peptides are exocytosed and accumulate to form plaques or 
soluble oligomers in the extracellular space. This accumulation primarily occurs in the 
cerebral cortex in associational areas (Hof and Mobbs, 2001) and is considered to be one of 
the early events of AD. Although the direct consequence of these AP aggregates is 
unknown, they may contribute to inflammation (reviewed by Minghettis, 2005) and altered 
ion transport (as reviewed by Kourie, 2001), both of which are possible players in AD. 
AP peptides are found in several isoforms including 1-40, 1-42, and 1-43 called 
protofibrils (Figure 2). The 42 residue protofibril has the highest tendency to aggregate 
and accumulate in the extracellular space. Although the 1-40 isoform does aggreagate, 
these oligomers are very unstable. The amyloid cascade hypothesis, which has been one of 
the most prominent theories of AD pathogenesis, holds that the fibrillar plaques formed by 
AP 1-42 are responsible for neuronal death (reviewed by Klein, 2002). Evidence has 
shown that the location of insoluble Af3 shows poor correlation to the region of cell death, 
and quantity of these plaques show poor association with degree of dementia (reviewed by 
Klein, 2002). Soluble oligomers of AP 1-42 however have a significant correlation with 
synapse loss. Levels of 1-42 are correlated with memory loss and regionally associated 
with neuron death, making soluble AP seem the more likely culprit in AP. 
Figure 2: a) Location and amino acid sequence of amyloid precursor protein. P and a 
cleavage sites shown on the lurninal side of the membrane. y cleavage sites (40 and 42) 
shown in the intramembrane domain. b) Non-amyloidogenic sequence of cleavage events 
( a  followed by y). c) Arnyloidogenic (pathologic) cleavage sequence (P followed by y). 
(taken from Vetrivel and Thinakaran, 2006) 
APP a-CTF APP P-CTF 
AlCD - AlCD 
Figare 2: Structure and cleavage of amyloid precursor protein 
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The means by which NFTs and AP form are unknown for non-familial AD. One 
possibility for the pathogensis is that the enzymes that generate these pathologies become 
abnormally localized in membrane domains called lipid rafts. 
Lipid Rafts and Sphingolipids 
The traditional model of cell membrane architecture describes a homogenous free- 
floating lateral organization of the cell membrane, though it has become clear that domains 
of tight lipid packing occur especially in the outer leaflet. These domains are highly 
enriched in cholesterol and sphingolipids that are able to pack tightly due to weak 
interactions of the carbohydrate head groups of the glycosphingolipids (as reviewed by 
Simons and Ikonen, 1997) and saturation of their hydrocarbon chains. These rafts are able 
to move freely within the membrane and can cluster upon interaction of the proteins that 
are associated with them (as reviewed by Rajendran and Simons, 2005). Various proteins 
preferentially partition into the rafts such as glycosylphosphatidyl-inositol (GP1)-anchored 
proteins, tyrosine kinases, G-proteins and other transmembrane proteins (Rajendron and 
Simons, 2004). These proteins are likely recruited to these membrane microdomains for 
the purpose of signaling and adhesion. Some of these proteins include enzymes whose 
activity is influenced by the integrity and clustering of these rafts (as reviewed by Simons 
and Ikonen, 1997). 
Interestingly, it has been recently shown that one of these glycosphingolipids, 
Sulfatide (ST) has levels that are uniquely reduced in AD. Han et al. (2002) showed that 
ST is decreased in AD tissue using mass spectrometry, and Gottfries et al. (1996) obtained 
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the same results using thin layer chromatography. This loss of ST and ensuing disturbance 
of lipid rafts may lead to abnormal distribution of enzymatic activity in the brain, resulting 
in the formation of the hallmark histopathologies of AD. 
It has been suggested that rafts may be involved in the formation of Afl plaques and 
NFTs of AD via the improper recruitment of enzymes or loss of compartmentalization (as 
reviewed by Cordy et al., 2006). The secretases and kinases that form the plaques and 
tangles, respectively, are known to be preferentially partitioned into these membrane 
domains (Kramer et al., 1999). Abnormal proportions of raft lipids have been shown to 
alter the &I.rities of these enzymes for rafts and therefore enzymatic activity (Kalvodova 
et al., 2005; Kramer et al., 1999). 
One example of enzyme activity conveyed by aggregation of raft proteins is that of 
fyn kinase as evidenced by Kramer et al. (1999). This example is especially relevant to the 
study at hand since fyn is involved in the hyper-phosphorylation of tau which results in 
NFTs (Lee et al., 2004). Glycoshpingolipids such as sulfatide, which are enriched in rafts, 
are synthesized at the same stage in the maturing OL as fyn coupled GPI-linked proteins 
get associated into rafts. In these early myelinating cells fyn kinase is highly active and 
linked to rafts. In OL progenitors or other membranes without rafts, fyn does not show the 
same activity. Also, addition of an antibody that leads to crosslinking of this fyn-coupled 
protein increases fyn activity. These results suggest that rafts are in fact a necessary 
platform for fyn enzyme activity that is directly implicated in formation of one of the 
hallmark AD microscopic pathologies (Kramer, 1999). 
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Cyclin dependant kinase 5 (cdk5) is also very pertinent to a raft-related theory of 
AD pathogenesis. Cdk5 is another of the numerous kinases responsible for the 
hyperphosphorylation of tau (Baunlan et al., 1993). Furthermore, cdk5 activity is 
regulated by p35, and activator that associates with the cell membrane (Monaco et al., 
2004), potentially with lipid rafts through N-terminal myristalation (Giese et al., 2005). 
Griffith et al. (2004) recently showed that only plasma membrane associated cdk5, which 
was complexed with p35, displayed activity. Improper membrane recruitment of this 
activator results in the mislocalized and prolonged activity of cdk5 potentially inducing tau 
hyperphosphorylation (Patrick et al., 1999) 
APP is also associated with lipid rafts. It has also been shown that BACE, the 
enzyme responsible for the P-cleaveage of APP (Hussain et al., 1999), is selectively 
partitioned into rafts (Ehehalt et al., 2003). This occurs since BACE undergoes 
palmitoylation, which targets proteins to rafts (as reviewed by Vetrivel and Thinakaran, 
2006). Addition of a GPI-anchor, which localizes proteins to rafts, to BACE increased the 
cleavage of APP at the f3 site (Cordy et al., 2003; Ehehalt et al., 2003). All four 
components of the gamma-secretase complex are also localized to these detergent 
insoluble membrane regions (Vetrivel et al., 2004). Also, Chen et al. (2006) showed that 
the intracellular domain of APP is associated with the raft protein flotillin-1. Using in vitro 
experiments in which concentrations of lipids found in rafts were varied, Kalvadova et al. 
(2005) showed that the ratio of lipids directly affects the activity of BACE. In addition, 
the alpha secretases responsible for normal processing of APP have not been linked to 
these lipid microdomains (Ehehalt et al., 2003). 
A critical problem is how to test our hypothesis that altered raft formation due to 
reduced ST leads to AD pathogenesis. To possibly solve this dilemma, we will draw on 
results from our laboratory studying a knockout mouse in which the synthetic enzyme for 
Sulfatide, cerebroside sulfotransferase (CST), has been eliminated. ST is greatly enriched 
in oligodendrocytes (Norton et al., 1975), the myelin-forming cells in the CNS. 
Interestingly, the knockout animals consistently show dramatic changes in the myelin 
sheath, and specifically in the axonal-oligodendroglial junctions in the paranodal region, 
which is normally maintained by adhesion molecules sequestered into lipid rafts. 
Importantly, these mutant animals show altered distributions of ion channels which are 
normally uniquely sequestered in the axon plasma membrane. Since this re-distribution 
has been seen in the mutant animals due to loss of ST and potentially abnormal lipid rafts, 
we will examine AD brains for a similar redistribution which may be reflective of more 
global membrane changes specifically related to the pathogenesis of AD. Furthermore, the 
ST knockout mouse shows gray matter (GM) changes including neuronal death (Marcus et 
al., 2006), a finding consistent with AD pathology. The following sections briefly discuss 
the role of ST in nervous tissue, the importance of normal axon-oligodendroglial junctions 
and summarizes our results from experiements utilizing the CST mutant animals. 
The role of ST in axon-oligodendroglial interactions 
ST is a glycosphingolipid predominately synthesized by OLs in the CNS and 
therefore primarily found in myelin (Vos et al., 1994; Han et al., 2002). ST is found in 
hydroxylated and non-hydroxylated forms. The hydroxyl group is on the alpha carbon of 
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the fatty acid chain. Carbon chain lengths of ST vary from 16 to 26. ST is present in 
white matter (WM) and GM although it is much more prevalent in WM (Han et al., 2002; 
Krafft et al., 2005). ST accumulation due to enzymatic dysfunctions is involved in the 
pathogenesis of various human diseases such as metachromatic leukodystrophy and 
Krabbe's Disease (Han et al., 2002). Cerebroside sulfotransferase (CST) synthesizes ST 
by the sulfation of galactocerebroside (GalC) (Honke et al., 1997) Figure 3). ST mediates 
various biological processes such as cell regulation, protein tracking, signal transduction, 
cell adhesion, neuronal plasticity, and morphogenesis (reviews by Vos et al., 1994; 
Ishizuka, 1997; and Merrill et al., 1997). 
ST may regulate neuronal viability by involvement in interactions between axons 
and OLs. Also, OLs are required fir development, function and survival of neurons. The 
interaction of the axon and OL at the paranode is likely the means through which OLs are 
involved in these functions. One way ST may mediate axo-glial interactions is via the 
maintenance of OL membrane domains. 
Axon-oligodendroglial junctions 
The junction of the myelin sheath and the axon is characterized primarily by the 
interactions of several membrane proteins at the paranode that serve in adhesion (Menegoz 
et al., 1997), signaling (reviewed by Arroyo and Scherer, 2000), and membrane 
compartmentalization (Einheber et al., 1997). (Figure 4) The adhesion molecule 
CASPR/Paranodin/NCPl (CASPR) is present on the axonal side and associates with 
neurofascin (Nfasc) 155 in the OL membrane for the purpose of adhesion (Tait et al., 
2000). The binding of CASPR to Nfasc 155 is essential for the formation of a structural 
component of the myelin-axon junction known as transverse bands. These "bands" 
provide the junction with a physical appearance that resembles invertebrate septate 
junctions which prevent fiee lateral difhsion of molecules along the membrane. When 
these junctions are compromised, both glial and neuronal protein domains are disrupted 
(Dupree et al., 1999; Bhat et al., 2001). 
The proper hctioning of the junction is crucial to maintaining axolemmal protein 
clustering. Although other factors may be involved (Kaplan et al., 1997), both initial 
clustering (Dugandzija-Novakovic et a1.1995) and long-term domain maintenance (Dupree 
et al., 2005) both require physical contact between the glial cell and the neuron. Sodium 
and potassium channel clusters are maintained by these junctions and are easily studied via 
immunohistochemistry (IHC). Additionally, clustering of these channels is a valuable 
indicator of junctional integrity (Dupree et al., 1999). 
Sodium channels are multi-domain membrane spanning proteins (Aidley, 1998) 
that provide the means by which sodium ions rapidly pass through the axolemma as action 
potentials travel down the axon. In the CNS two types of sodium channels (Navl.2 and 
Navl.6) have been found clustered at the node (Boiko et al., 2001; Kaplan et al., 2001). 
Navl.2 is the immature form and is initially expressed in the CNS nodes of Ranvier. As 
myelination continues, Navl.2 is replaced in over 90% of the CNS nodes by the mature 
form Navl.6. Following a demyelinating event (Dupree et al., 2005) and in 
dysmyelinating animal models (Craner et al., 2003; 2004; Suzuki et al., 2004), Navl.2 
Figure 3: Sulfatide is synthesized from the addition of a sulfate group to 
galactocerebroside by the enzyme cerebroside sulfotransferase (CST). The 
galactocerebroside is synthesized by the addition of a galactose group to ceramide by the 
enzyme ceramide galactotransferase (CGT). (taken from Coetzee et al., 1998) 
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Figure 3: Synthetic pathway of sulfatide 
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Figure 4: (Upper left) A single PNS internodal segment is shown with the myelin sheath 
unwrapped. The segment is flanked by paranodes and nodes of Ranvier. (Upper right) an 
oligodendrocyte is shown with three processes terminating in three internodal segments, 
again with the myelin sheath unwrapped. (Below) An axonal node of Ranvier is shown in 
longitudinal-section. The three major regions are depicted: node, paranode, and internode. 
The juxtaparanode is the internodal region immediately adjacent to the paranode on the 
internodal side. As shown, sodium @a+) channels cluster in the node, CASPR 1 Paranodin 
accumulates at the paranode, and rectifying potassium channels (Kvl.1 and Kv1.2) are 
concentrated at the juxtaparanode. (Taken from Dupree, 1996) 
Figure 4: Nodal / Paranodal Region Architecture 
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expression is significantly upregulated, suggesting that Navl.2 may be used as a marker of 
de- and or dysmyelination. 
CST Null Mouse 
Work in an animal model demonstrates the critical role of ST in the maintenance of 
the paranodal region. Honke et al. (2002) engineered a CST null mouse in order to 
determine whether a single gene and enzyme were responsible for the production of ST. 
This mutant mouse displays minimal deficiencies through the early stages of development. 
By 6 weeks of age these animals exhibit profound motor dysfunction in their hind limbs 
accompanied by altered axo-glial interactions. These findings were confirmed by Marcus 
et al. (2006), who showed that the absence of ST does not result in the gross disruption of 
development, but that ST is essential for the maintenance of myelin and axon structure. In 
the aged CST null mouse, nodal structure is compromised, axon diameter is decreased, and 
neurons appear to be lost. Additionally, Ishibashi et al. (2002) reported that the initial 
clustering of K+ and Na+ channels was only mildly altered in the young ST null mice; 
however, with age and in the absence of demyelination, clusters of both the Na+ and K+ 
channels were lost, and K' channel clusters that remained were shifted to the paranodal 
region. In addition, CASPR was dispersed throughout the internode rather than clustered 
at the paranode. Taken together, these studies strongly suggest that ST is critical for the 
maintenance of neuronal membrane organization, function and even survival. 
Proper localization of sodium channels to the node of Ranvier and potassium 
channels to the juxtaparanodal region are maintained by the integrity of the paranode. Is it 
possible to use this organization of protein domains, which is maintained by rafts and 
paranodal junctions, to measure changes in the interface between OLs and axons in AD. It 
is feasible to observe such modifications by uitilizing irnrnunohistochemistry to visualize 
any rearrangement of ~ a +  and K+ channels in AD tissue. 
Rationale and Hypothesis 
The cause of NFTs and AP plaques, the hallmark AD pathologies, is not clear. 
Tangles and plaques are formed by enzymes that are preferentially sequestered to 
membrane domains called lipid rafts. Sulfatide is essential for the proper structure and 
function of lipid rafts. Our laboratory has demonstrated that reduced ST results in altered 
membrane domains that are normally maintained by adhesive contacts and functional lipid 
rafts. Sodium channel clusters at the nodes of Ranvier are lost as a result. This change in 
sodium channel localization provides a useful measure for assessing overall alterations in 
paranodal junctions and rafts. In this study, normal and age-matched AD brains will be 
immunolabeled in order to evaluate the amount of clusters present. I hypothesize that 
reduced ST in the AD brain disrupts lipid raft membrane domains as evidenced by loss of 
sodium channel clusters at the node of Ranvier. 
Materials and Methods 
Tissue Acquisition and Storage 
Human brain tissue was acquired fiom the University of California at Los Angeles 
(UCLA) brain bank (Table 1). UCLA provided samples of occipital lobe. Tissue from 
severe AD, mild AD and non-AD patients (based on Braak and Braak staging) was 
requested, and 3 samples fi-om each category were received. 
The brain bank ranked each patient according to the Braak and Braak criteria and as 
cognitively normal or having dementia prior to death. The Braak and Braak stage refers to 
the presence and location NFTs in the post-mortem pathological analysis. Lower Braak 
and Braak scores (Table 1) correlated with 'no dementia' diagnosis, and higher scores with 
diagnosis of 'dementia.' 
The brain bank provided information on the duration between death and collection 
of the tissue (ranging fiom 7 - 28 hours) although information for five of these samples 
was lacking. All samples were fiesh frozen and shipped on dry ice. Upon receipt, the 
Table 1: Information regarding the diagnosis of the patients and the post-mortem 
pathologic state of the tissue obtained. Time post-mortem refers to period between death 
and tissue collection. Braak and Braak stage was determined post-mortem primarily by the 
extent of NFTs. 
Table 1: TISSUE INFORMATION (1 sample each: occipital lobe) 
20030027 
20030030 
AD-SEVERE 
AD-SEVERE 
Not provided 
7:OO 
VI 
V 
Reagents Used 
Tissue sections were stained with Quickstain (American Master*tech Scientific, 
Inc.) in order to study the integrity of the tissue. The lx  phosphate buffered saline (PBS) 
used for IHC was composed of 160.lg NaCL, 28.8 g Na2HP04, 4.8 g K&P04, 4.0 g KC1 
dissolved in 20L of filtered water and made at pH 7.4. In order to localize sodi~mi and 
potassium channels, commercially available antibodies were used as previously described: 
pan Na channel antibody (Sigma S8809) (Dupree et al.., 1999; Marcus et al., 2001), Na 
channel Nav 1.2 (Upstate Biotechnology) (Dupree et al., 2005), and Kvl . 1 potassium 
channel antibody (Upstate Biotechnology) (Dupree et al., 1999). To assure that the density 
of myelinated axons was comparable among samples, tissue sections were immunolabeled 
with antibodies directed against neurofilaments (SMI33, Covance Research Products) and 
the MT associated protein known as MAPlb (AA6, Sigma). An antibody against 2',3'- 
Cyclic nucleotide 3'-phosphodiesterase (CNPase, SMI91, Covance Research Products) was 
used to label myelin in order to distinguish between gray matter and white matter. 
The standards for ST and cerebrosides were obtained from Avanti Polar Lipids 
(cat# 13 13 05 [ST] and 13 1303 [Cerebrosides]). A protease inhibitor cocktail (Sigma cat# 
P8849) was used in the tissue homogenization process. Protein assay was performed using 
a BSA kit obtained from Pierce Biotechnology, Inc. 
Tissue Handling 
The fresh frozen tissue was immediately stored at -80° C upon receipt. The tissue 
was then slightly thawed in order to harvest small samples of WM enriched tissue that 
were embedded in OCT compound (Tissue-Tek, Optimum Cutting Temperature, Sakura 
Finetech). The OCT embedded tissue blocks were placed immediately on dry ice and 
again stored at -80" C. Each tissue block was then sectioned at a thickness of 1 Opm using 
a cryostat at -20° C. Twenty-five consecutive sections were placed on slides (ProbeOn 
Plus, Fisher), appropriately labeled (specimen#, brain region, section thickness, and slide 
order), and stored at -80" C. 
Immunostaining protocol 
Imrnunohistochemical staining was performed according to the method of (Dupree 
et al., 1999) Slides were removed from the freezer and allowed to air dry for 30 minutes. 
Excess OCT was cut away from the perimeter of the tissue. A hydrophobic barrier was 
applied around the section using a PAP pen (Super PAP Pen, Electron Microscopy 
Sciences) to assist in maintaining incubation solutions on the section. Dried slides were 
labeled to indicate antibody and incubated in -20" C acetone to permeabilize for 10 min. 
The slides were then rinsed three times in phosphate buffered saline (PBS) for five minutes 
each followed by a 30 minute incubation in a blocking solution. The blocking solution 
contained -5% cold water fish skin gelatin (approximate since it was added dropwise and 
is extremely viscous, 10% fetal calf serum, and 0.1% Triton-X 100 in PBS. Following the 
block, sections were incubated in the appropriate primary antibody at the concentration 
shown in Table 2. All antibodies used in this study have been well characterized in 
previously published studies from laboratory (Dupree et al., 1999; 2005; Marcus et al., 
2002). The tissue remained in primary antibody overnight at 4" C in a humidified chamber 
to prevent drying. The following day, three PBS rinses and 30 min blocking steps were 
repeated, followed by a 90 min secondary antibody (Table 2) incubation in the dark at 
room temperature. The secondary antibodies, which were fluorescently conjugated, were 
also diluted in the blocking solution to a concentration of 1 :200. The slides were then 
rinsed three times in PBS for 5 minutes and mounted with Vectashield (Vector 
Laboratories) medium and a cover slip was applied. 
Controls, negative andpositive 
Mouse tissue was analyzed along with human tissue under the same conditions in 
order to confirm the specific binding of the antibodies. Since the specificity of the 
antibodies used have been established in mouse tissue, and labeling patterns were 
consistent between the two animals it was concluded that binding in the human occurred 
and was specific. Labeling with different primary antibodies and the same secondary 
revealed unique patterns of labeling and therefore assured the specificity of each. This 
provided both positive and negative controls for the primary antibody. Tissue was also 
stained with primary antibody and no secondary to ensure that the primary antibody did 
not fluoresce. In order to confirm that the secondary antibodies only bound to the primary 
antibodies used, IHC was performed in the absence of any primary antibody under 
identical conditions. 
Table 2: Primary and Secondary Antibodies Used 
Table 2: Primary Antibody Concentrations and Corresponding Secondary 
Antibodies with Conjugated Fluorochromes 
Primary 
Antibody 
Dilution 
Secondary 
Antibody 
(1:200) 
Kvl . 1 
1:lOO 
Alexa 
594 
Anti- 
Mouse 
Pan NaCh 
1 : 100 
Alexa 
594 
Anti- 
Mouse 
MAP 1 b 
1:lOO 
Alexa 
594 
Anti- 
Mouse 
NaCh 1.2 
1:lOO 
Alexa 
594 
Anti- 
Rabbit 
Neurofilament 
1:lOOO 
Alexa 
594 
Anti- 
Mouse 
CNPase 
1:lOOO 
Alexa 594 
Anti- 
Mouse 
Analysis of Sodium Channel Clusters 
Quickstain 
Each sample was stained with Quickstain in order to confirm the integrity of the tissue. 
Tissue was analyzed for presence or lack of artifactual spaces. White matter without 
significant space was deemed appropriate for IHC. One drop of dye was placed on a tissue 
section for ten seconds and then rinsed in phosphate buffered solution (PBS) for 10 
seconds. Slides were dried and cover slipped with immersion oil. Slides were visualized 
under a Nikon Eclipse 800M bright field microscope and images were recorded at the GM 
I WM interface at 40x and at 200x in each of the two regions (GM and WM). 
Representative fields for each tissue section were chosen and recorded. Consecutive 
sections were analyzed by Quickstain and by IHC for NaCh clusters. 
The first step in analyzing each slide was to distinguish between WM and GM. 
Prior to nodallparanodal protein data collection, myelin markers were used for this purpose 
(as previously discussed). In addition to the myelin antibody markers, distinct patterns of 
lipofuscin (LF), corresponding to the WM and GM region, was observed. Subsequently, 
LF patterning was used to make the distinction. 
Confocal Microscopy 
After confiiing areas, of white matter, all sections were imaged using the Leica 
TCS SP2 AOBS or Zeiss LSM510 NLO META confocal microscopes housed in the VCU 
Microscopy Facility. A minimum of six fields were collected, depending on the size of the 
WM region in each sample. In all cases, except for Kvl .l data collection, a single optical 
plane was scanned. In the case of the Kvl . 1 , a maximum projection of a z-stack of 10 
optical planes at a step size of 0.4 pm was collected in order to capture pairs of potassium 
channel clusters in different planes. Gain and offset settings were held as consistent as 
possible from fiame to frame. Following is a list of settings used for image collection 
(Table 3). 
Digital Removal of Autoflourescence 
One of the difficulties of fluorescent labeling of human tissue is the presence of the auto- 
fluorescing substance known as lipofuscin (LF). LF accumulates in cell bodies and is 
composed of lipids, metals, organic molecules, and biomolecules (as reviewed by Brunk 
and Terrnan, 2002). LF emits fluorescence in the red spectrum when excited with 488 and 
594 nm light. The majority of the experiments were performed with a secondary antibody 
that was optimally excited at 594 nm and which also emitted light in the red spectrum. 
Since both the fluorescent label and LF emitted in the same region of the spectnun, it was 
not possible to discern specific labeling from LF autoflourescence. Two techniques were 
employed to resolve this issue. On the Leica confocal microscope, a subtraction technique 
was used. 
Table 3: These settings were determined to be optimal for the information desired. 
Table 3: Confocal microscope settings 
Gain Offset Pinhole Zoo Objective Format Line Voxel 
Diam. m Av Size 
Leica 700 +I- 71 0 +I- 0.05 115 -pm = 1 2 63x 1024x 4 116.14 x 
Airy Unit 1024 116.14 
nm 
Zeiss 700 +I- 63 0 +I- 0.05 112 pm = 1 2 63x 1352x 4 98.82 x 
Airy Unit 1352 98.82 
nm 
Briefly, when excited by the 488 nm laser, ordy LF fluorescence was present, and thus all 
pixels visible in this image corresponded to LF. Another image was taken under 594 nm 
light that contained specific labeling for the antibody used as well as LF autoflouresence. 
All pixels from the 488 image were subtracted from the 594 image leaving only pixels 
corresponding to the protein of interest. The subtraction method was not ideal, however, 
since in the instance of pixels that overlapped between the two channels, the signal of the 
desired channel was diminished or eliminated. 
In addition to the subtraction method, autoflourescence and antibody labeling were 
also distinguished by the Zeiss spectral unmixing capabilities of the META system of the 
Zeiss confocal microscope. With the exception of the neuronal markers to neurofilaments 
and MAP 1 b, used to determine axon density, all of the IHC experiments were completed 
on the Zeiss confocal microscope in order to use its META capabilities. Since only ratio 
between the clusters (measured on the Zeiss) and axon density (measured on the Leica) 
was needed, data from one microscope could be used to analyze data from the other. The 
META detector was a polychromatic 32-channel detector for fast acquisition of lambda 
stacks and allowed simultaneous acquisition of up to 8 channels. Multiple images of the 
same field were gathered - each scanned using incremental emitted wavelengths from 447- 
704 nm. These data were compiled in order to create profiles of the fluorescing intensity 
for each emitted wavelength at each pixel. The profiles were curves plotted with 
fluorescent intensity on the y-axis and the spectrum of emission wavelengths on the x- 
axis. 
Profiles of specific pixels were then chosen as representative of each fluorescent 
species (i.e. 594, lipofuscin, background). All signals that identified with profiles for LF 
and background were digitally removed from the image. Thus, only pixels corresponding 
to the 594 fluorochrome (which was conjugated to the secondary antibody and 
corresponded to the immunolabeled protein of interest) remained in the recorded image. 
This procedure, called linear untnixing, was a more precise method of identifying which 
pixels correspond to specific secondary antibodies since it was able to distinguish even 
between overlapping pixels based their the spectral fingerprints (Figure 7). 
Quantitation of sodium channel clustering 
Following spectral unrnixing, the clusters of sodium and potassium channels were 
counted with IPLAB (Scanalalytics, Inc) software using segmentation analysis. The 
threshold was set such that the number of clusters counted for several fields corresponded 
approximately to the numbers generated by counting manually. In the cluster counts 
IPLAB's segment quantification feature was used with settings including pixels with 
intensities between 50 and 255 and clusters having areas of between 9 and 1000 pixels 
(9,800 nm2 1 pixel). The threshold (intensity) and cluster size settings were optimized in an 
attempt to reproduce the choices made by eye as to what constituted a cluster and to 
reproduce manual counts. These setting were chosen by first counting several different 
frames manually. The same frames were then subjected to quantification analyses with 
various combinations of intensity threshold and number of pixels per cluster settings. The 
optimal settings were chosen when the clusters outlined by the software resembled the 
shape and size of those seen in the raw images and the numbers of clusters counted by 
IMAGEJ (httv://rsb.info.nih.gov/ii/ ) were similar to those that were manually obtained. 
To assure comparisons of structurally similar brain regions, axon fiber densities 
were calculated using axonal markers based on percent labeled pixels per field. As 
previously indicated, an antibody to MT associated protein 1 b (MAP 1 b), which is a good 
indicator of axonal MTs, was used as well as an antibody directed against neurofilaments. 
For this quantification, Image J software was utilized to count all pixels in a field that had 
intensities between 70 and 255 on the thresholding feature of the software. This range was 
chosen by simultaneously viewing thresholded and original images to create and image 
which only revealed pixels pertaining to axons. Sodium channel clusters were counted and 
then standardized based on the obtained axon densities. Cluster counts were divided by 
axon densities generating numbers in clusters 1 Clm2 of axon / field. 
Statistics 
One section of each sample was analyzed. Every ninth field was recorded such that 
a nzinimum of six fields analyzed depending on the amount of WM per sample All values 
are presented as mean +/- standard deviation (SD). All data were statistically analyzed by 
t-test or analysis of variance (ANOVA) where appropriate, using Sigmastat software 
package (Systat Software Inc.) with the assistance of Dr. David Sirnpson, Associate 
Professor of Anatomy and Neurobiology at VCU. Significance was set at p < 0.05. 
Thin layer analysis of sulfatide content 
Lipid Extraction 
Lipids were extracted as previously published by Sato and Yu (1990). Dr. Carmen Sato- 
Bigbee, Associate Professor of Biochemistry and Emilse Sanchez guided this portion of 
the study and all TLC procedures were conducted in Dr. Sato-Bigbee's laboratory. 
Briefly, for the extraction, 1 1 Omg of WM enriched samples were harvested (confimed 
by visual inspection). For each specimen, the tissue sample was homogenized in 500uL 
of PBS that contained a protease inhibitor cocktail (Sigma cat# P8849) on wet ice. An 
aliquot of homogenate was set aside at 4' C for protein analysis. A 200uL aliquot of the 
homogenate was added to 40 volumes of choloroform:methanol2: 1. All of the steps after 
homogenization were performed at room temperature. Each sample was then centrifuged 
at 2000 rpm for 1 0 min. The supernatant was transferred to a fiesh 1 5rnl plastic 
graduated tube (Falcon, Fisher Scientific). Distilled water in the amount of 20% of the 
original solvent volume was then added. The sample was shaken, allowed to settle, and 
centrifuged at 1000 rprn for 5 min. The top of the upper layer (the aqueous phase) was 
marked on the tube and the upper layer was removed. The tube was filled to the mark 
with Ch1oroform:Methanol:Water (4:48:47). The sample was shaken, settled, and 
centrifuged at 1000 rpm for 5 rnin. The upper 2 layers, the aqueous and interphase, were 
removed and the sample was dried under nitrogen in order to prevent oxidative 
degradation. The sample was then resuspended in chloroform:methanol2: 1 in 20% of 
initial solvent volume. After the extraction, volumes of the organic layer, which 
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contained the lipids, varied, suggesting that water content varied among the samples. 
These volume values were used later to standardize the TLC results. 
To determine which bands correlated with ST, cerebroside and ST standards were 
run next to samples on the TLC plate. The standards for ST and cerebrosides were 
obtained from Avanti Polar Lipids (cat# 13 1305 [ST] and 13 1303 [Cerebrosides]). Stock 
solutions of standards were at 1.7 pg/pL in 2: 1 chloroform:methanol. 
Preparation of tissue 
Optimal loading amount of the sample was predetermined for GM and WM based 
on a TLC of a series of increasing amounts of lipids. Loading volumes were made by 
pipetting various masses of total lipids into disposable glass culture tubes (Baxter 
12x75mm) and drying under nitrogen. Samples were then redissolved in 10 pL of 2:l 
Chloroform:Methanol, the optimal TLC loading volume as previously determined by 
(Sato and Yu, 1990). The samples were cortical regions enriched in WM (1 1 Omg). The 
mass of the human samples was chosen based the amount of WM available. A TLC of a 
series of amounts of lipids (Figure 12) was performed on non-diseased WM and GM 
samples at concentrations: 5, 10, and 20 pL (dried under nitrogen and redissolved in 10 
pL of choroform:methanol). The 5uL band was too faint and the 10 pL band too large 
(Figure 13). Therefore, 7.5 pL was determined to be the optimal load for WM. One and 
three pL volumes of standards (1.7 ug / pL) were diluted to 10uL and loaded. 
TLC Plate loading and developing 
The TLC protocol was as follows: The silica gel plate (obtained fiom EMD 
Chemicals cat# 1 176416) was activated by heating at 130' C for two hours. The samples 
were immediately loaded on the plate on 1.0 cm lines spaced 0.5 cm apart. The material 
was loaded 1.5 cm fiom the bottom of the plate to ensure that the solvent in the TLC well 
did not contact the sample. A 25mL Hamilton glass syringe with a blunt tip was used for 
loading. Samples were added dropwise. The plate was placed vertically in the well such 
that less than 1.5 cm of the plate was immersed in the solvent solution of methyl 
acetate:chloroform:methanol: l-propano1:water (2528: 10:25:7) and the well was sealed. 
The samples were allowed to run until the progress of the mobile phase had visibly 
ceased to progress. The plate was stained with orcinol which has been shown by Zoller et 
al. (2005), to be especially effective in staining ST and the images were recorded with a 
Fluorochem Imaging system (Alpha Innotech) 
Protein Assay 
In order to further standardize our TLC data, a protein assay was performed. 
Aliquots of the tissue homogenate were used to determine the total concentration of 
protein in the sample. 300uL of the initial 500uL homogenate of the tissue samples was 
used for the assay. This volume was diluted with 1mL of radioimmunoprecipitation 
(FUPA) buffer solution and further homogenized in a 15rnL disposable tissue grinder 
(VWR International, 47732-446). RIPA buffer was added to reach a dilution of 1 :20 of 
the original 300pL aliquot. The tissue was further homogenized in a glass tissue grinding 
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tube with a ceramic pestle bit in a ring-stand mounted drill. The sample was then assayed 
for total protein content at several dilutions. The assay used was a Pierce BSA kit that 
measures total tryptophan residues. The assay was performed on each sample in 
triplicate along with a standard curve using bovine albumin. Protein concentrations were 
measured using an ELISA plate reader at 570 nrn. 
Quantification of TLC's 
The densities of bands were measured with ImageJ image analysis software. 
Densities were calculated by selecting the combined hydroxylated and non-hydroxylated 
ST bands and calculating the area under the peaks in curves corresponding to the bands. 
From the densitometry data, a total number of optical density units for the entire 1 lOmg 
tissue sample was extrapolated. Considering that the number of OD units for the ST 
bands for a given lane correspond to the amount of ST in volume of lipids loaded, a 
concentration in the form of OD units per mL of lipid extract can be calculated. Using 
the fiaction of the homogenate which the lipid extract constitutes, OD units per mL of 
homogenate can be calculated. Since the tissue was homogenized in 500mL of PBS, 
multiplying the OD units of ST / mL homogenate by 500 will give total OD units of ST 
for the tissue sample. A total amount of protein (in mg) for the harvested sample was 
calculated. A standard curve was generated from the ST standards of known 
concentration versus optical density enabling the conversion of the density of ST in the 
samples to be converted to mass. The densities of the ST bands were standardized 
relative to the cerebroside and cholesterol lipid bands as well as to total protein content. 
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Results were reported as pg ST / pg protein and pg ST / pg cerebroside. A one-way 
ANOVA among the sample groups was performed on the standardized values for ST 
content. 
Results 
Immunohistochemistry 
Immunohistochemistry (IHC) techniques were employed to evaluate the 
competency of the axo-glial interactions in the AD tissue based on the clustering of 
sodium channels. For these studies, fiesh frozen tissue saniples were immunolabeled for 
several paranodal and nodal proteins known either to mediate axo-glial interactions or 
whose distribution is directly altered when these mediations are compromised (Menegoz 
et al., 1997; Dupree et al., 1999; Rios et al., 2000; Ishibashi et al., 2002). 
Tissue samples 
Quickstain analysis revealed that the WM of the most samples was in tact (Figure 
5). Some holes were present in GM, though minimal. Only those tissues which were 
judged to be in good condition were used. 
Gray and white matter regions determined by myelin markers and lipofuscin patterns 
As shown in Figure 6, distinct patterns of lipofuscin exist for gray matter and 
white matter. These regions were initially determined by myelin markers. CNP was used 
as a myelin marker and provided very clear visualization of distinct GM and WM 
regions. CNP labeling confirmed that the distinct patterns of a~ltofluorescence was a 
reliable method of differentiating GM and WM regions. 
Axonal orientation and girth consistent among samples 
First, to assure that .the density of myelinated axons was comparable among 
samples, tissue sections were immunolabeled with antibodies directed against 
neurofilaments (SMI33, Covance Research Products) and the MT 
associated protein known as MAPlb (AA6, Sigma). An antibody against 2',3'-Cyclic 
nucleotide 3'-phosphodiesterase (CNP) was used to label myelin in order to distinguish 
between GM and WM. 
Using qualitative assessment, it was determined that the regions analyzed 
contained homogenous populations of axonal processes with respect to caliber and 
density. Due to the fact that the qualitative analysis showed uniformity among samples 
and that most of the axons in all samples were in oblique section, density was determined 
to be a reliable correlate to axon length. Since the number of clusters is dependant on 
axon length, the cluster counts were standardized based on axon density. In other words, 
the number of ion channel clusters per field was divided by the density of axonal staining 
per field. 
Figure 5: Samples were stained with Quickstain to assess degree of artifact. Images 
shown are representative of condition of the typical sample. What little artifact is present 
is in the form of spaces within the tissue as shown by the arrows, which is probably due 
to freezing. Typical fields of A) GM, B) WM. The GM regions consistently show greater 
artifact than WM. 
Figure 5: Typical Tbne Samples Show Only Minor Artifact 
A) Gray hiatter 
B) White Matter 
Figure 6 a, b: a) GM exhibits larger clusters of lipofuscin autoflouresence yet the clusters 
are less uniform in distribution, shapes and sizes compared to b) WM which lacks neuronal 
cell bodies and thus smaller clusters of LF are observed in a more regular pattern. Neither 
(a) nor (b) were treated with primary antibody, but were otherwise subjected to the 
identical protocol as the other IHC experiments, and thus no specific immunolabeling is 
present in these images. 
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Fire 6 a, b: Lipofnscin patterns used to differentiate gray and white matter 
a) Gray Matter 
b) White Matter 
Figure 7 a, b: a) Lipofuscin (yellow) makes sodium channel clusters (white) difficult to 
identify. b) Lipofuscin signal has been removed via lambda scanning and linear 
unrnixing . 
Figure 7: Lipofuscin removal made sodium channel cluster identiileation passible 
a) Pan NaCh labeling with lipofuscin 
. 
r .I b . b  * . -
I 
b) Pan NaCh Labeliug without lipofuscin 
I I I 
Axonal markers revealed slight variations in axon densities 
Axonal markers to MAPl b and neurofilaments were used to compare relative axon 
densities between brain regions. Both qualitative and quantitative assessments were used 
to compare tissue samples. Among the samples, axon girth appeared constant; few axons 
were longitudinally oriented; most axons were transversely or obliquely oriented. The 
results from this analysis are shown below in Table 4 and Figure 8. These densities were 
used to standardize the protein clustering values. MAPl b yielded a mean axon density of 
2 1 7 +I- 105 pixelslfield for severe AD, 200 +I- 105 for mild, and 173 +I- 1 9 for non-AD 
with a p value of 0.9. Neurofilament densities were 186 +I- 75 for severe, 143 +I- 23 for 
mild, and 174 +/- 36 for the controi and a p value of 0.6. 
Nodal architecture was intact 
IHC studies on the ST null mouse revealed dramatic alteration in protein clusters 
(Ishibashi et al., 2002). To test whether the nodal changes seen in the ST null mouse were 
also present in AD, the distribution of several CNS nodal and paranodal proteins was 
determined. Negative control labeling with secondary antibodies in the absence of 
primary antibodies revealed no specific labeling. 
Sodium channels were unchanged between sample groups 
In the non-standardized cluster counts from the pan NaCh there was no significant 
difference between AD and non-AD as seen in Table 5 and Figures 9, 10, and 11. Age- 
Figure 8: Variability in axonal labeling among samples: Samples were labeled 
with antibodies directed against axonal cytoskeleton in order to calculate axon 
density 
Figure 8 a, b, c, Bi d: Variability in axoml labeliag seen among samples 
Table 4: Axon densities were measured in number of pixels per fiame of labeling for 
Maplb and neurofilaments above an intensity of 50 (on a scale of 0-255). Means and 
standard deviations are given for each disease or non-disease group. 
Table 4: Axon densities varied among samples 
Figure 9 a, b: Pan NaCh Labeling Unchanged Between Non-Alzheimer's and 
Alzheimer's Tissue These figures demonstrate the clustering seen in sodium 
channels at the nodes of Ranvier. Mouse monoclonal pan NaCh primary antibody 
was used at 1 : 100; Alexa 594 conjugated anti-mouse secondary antibody at 1 :200. 
Fire 9: Pan Sodium Channel Labeling Unchanged 
b) Alzheimer's Pan NaCh Labeling 
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matched, non-demented brains revealed the same cluster mean (329 +/- 68 clusters/field) 
as the severe diseased (308 +/- 170 clusters/field) and the mild diseased (28 1 +/- 104) 
brains. When standardized against axon density (Figure 1 I), the pan NaCh antibody again 
revealed no significant difference (P = 0.235) among the sample groups as determined by 
aone-way ANOVA. Raw and standardized means among groups showed similar trends. 
Navl. 2 sodium channels unchanged 
Despite the fact that the pan NaCh antibody showed no difference between sample 
groups, it remained to be determined whether clustering of specific Na channel isoforms 
was altered. Quantification of the clustering of Nav 1.2 removed this ambiguity as well as 
serving as a marker for demyelinating pathology. This antibody revealed no significant 
difference (P = 0.142) between AD and non-AD groups for either clusters or total area 
(Table 6). It was therefore concluded that there were no differences between these sample 
groups for the Nav 1.6. 
Thin Layer Chromatography 
No Difference in ST Levels Among Samples 
Considering the premise of the study was the previous findings of Gottfries, 
Karlsson, and Svennerholni (1996), and more recent data from Han et al. (2002), who 
reported a 60% decrease in WM ST, TLC was employed to c o n f i  these results. Upon 
Figure 10: Shown in purple are the average number of total pixels per field of MAPl b 
labeling (representing axon density). In red are the average number of clusters of sodium 
channels per field. The first three pairs represent severe AD, the second three, mild, and 
the third, non-diseased. This figure demonstrates how the axonal marker MAPl b and 
NaCh clustering varied in parallel with each another. 

Figure 11: This figure shows the mean number of clusters per field divided by the mean 
axonal density as determined by MAPlb immunolabeling. A slight trend can be detected 
in this graph, though an analysis of variance revealed any differences to be insignificant. 
I q  M ce ii$t'Sdhm C!hfm&l C b t m  Standardized with MAPlb 
Table 5: This table contains mean number of clusters per field for NaCh for the three 
sample groups of the tissue in the 'NaCh' clusters columns. Columns headed 'NaCh' / 
MAP1 b' or SMI 33 show cluster counts standardized by dividing by axon density. 
Table 5: Ne DHZhmee4n sodium d Potassixam Channel Cl'llsters 
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initial inspection by eye, there appeared to be no difference among sample groups (Figure 
13). Densitometry with ImageJ analysis software revealed that there was a trend towards a 
decrease in ST in the AD groups although the differences were not significant. One TLC 
was preformed and densitometry was performed on one band of each sample. In the 
analysis ST levels were determined to be slightly higher in the control group than in the 
mild and severe AD groups (Table 7, Figure 13). The control group revealed 0.48 +I- 0.05 
pg ST / OD units of cholesterol compared to the mild group, which presented a ratio of 
0.36 +I- 0.01. Similarly the severe group exhibited a ST to cholesterol ratio of 0.36 +/- 
0.07. A one-way ANOVA gave a P-value for these three groups of 0.201. 
Table 6: Shown are total segments/field and areaslfield of labeling of anti-Navl.2 primary 
antibodies in the tissue 

Figure 12: This figure shows from left to right - two lanes of cerebroside standards: 0.02 
and 0.06 pg; two lanes of ST standards (2 bonds: non-hydroxylated above hydroxylated) 
0.02 and 0.06 pg; three lanes of WM enriched non-diseased human brain extract: 5, 10,20 
pL of extract; and three lanes of GM at 5,10 and 20uL of extract. Nothing was loaded on 
the empty lane between the 5 pL and 10 pL GM. 
Figure 12: 15pL Determined Optimal Loading Volume for White Matter 
0.02p.gO.06pg 0.02pg 0.06p.g 5p.L l0uL 20uL 5uL 0 lOuL 20uL 
Cerebrosides Sulfatide White Matter Gray Matter 
Figure 13: The TLC shows the various lipid bands found in the white matter enriched 
human brain tissue samples. The top band is cholesterol (Ch), the next two bands are 
cerebrosides (non-hydroxylated above hydroxylated) as can be seen by the cerebrosides 
(C) standard bands seen on the left. The next two bands correspond to ST (non- 
hydroxylated above hydroxylated) as seen in the (ST) standards the left. 
Figme 13: No Change in White Matter Subtide Levels Among Sample Groups 
I - 
36 24 
Control 
21 18 28 
Mild AD 
27 30 17 
Severe AD 
S C 
Table 7: Shown are the standardized optical densities of the ST bands from TLC analysis 
of the tissue. The ST was standardized by the cholesterol band as shown in the 'ST / 
cholesterol' column. ST was also standardized by protein. 
Table 7: No Difference in White Matter Sulfatide Levels 
W S T I P ~  PgST/Pg 
Sample Cholesterol Protein 
Severe 27 0.36 48 
30 0.29 81 
17 0.43 62 
Mild 
Control 
DISCUSSION 
Alzheimer's disease is characterized by accumulation of AP plaques, NFTs and 
neuronal death, though the cause of these hallmark pathologies remains unclear. Enzymes 
that are involved in the formation of AP plaques and NFTs are associated with the 
neuronal membrane (Kramer et al., 1999; Ehehalt et al., 2003), and proper partitioning in 
the normal membrane prevents inappropriate interaction of axolemmal enzymes and 
potential substrates (reviewed by Simons and Ikonen, 1997). Sulfatide is essential for the 
proper structure and function of lipid rafts, and Han et al. (2002) recently reported that ST 
is significantly reduced even in the earliest stages of AD. Thus, I hypothesized that 
reduced ST in the AD brain would disrupt lipid raft membrane domains as evidenced by 
loss of sodium channel clusters at the node of ranvier. In the present study, membrane 
domain organization appeared to be in tact in AD tissue. Sulfatide levels also appeared to 
be unchanged. I was therefore unable to support my hypothesis. 
Protein Organization 
Sodium channel clustering was used as a marker to determine membrane domain 
organization since it is well characterized and easily labeled. Clusters were unchanged in 
AD tissue at both early and late stages as compared to controls. 
Simons and Ehehalt, 2002 and Ehehalt et al., 2003 suggested that rafts are involved Af3 
formation. When cholesterol was depleted Af3 generation increased and a-cleavage (non- 
amyloidegenic) increased. Cholesterol depletion would disrupt raft organization and 
render more of the usually raft associated APP in non-raft membrane domains. 
We decided therefore to analyze protein organization in the axolemma as a measure of raft 
integrity. Imrnunohistochemical analysis, confocal microscopy, and digital quantification 
were rigorously performed. 
Our findings do not suggest a loss in neuronal membrane organization, suggesting 
that the increased f3-amyloidogenic processing in AD is due to some mechanism other than 
rafi disruption This supports the findings of Simons since raf3 disruption would be 
expected to increase non-disease causing APP processing and decrease Af3 production. 
This opens the possibility that hyper aggregation of rafts is actually responsible for the 
increased P-cleavage activity that ultimately leads to the formation of amyloid plaques. 
Sulfatide in Alzheimer's Disease 
In the thin layer chromatography analysis of the lipid content, ST was not 
significantly different in the AD and non-AD brains. Our findings are in contrast to those 
of both Han et al., 2002 and Gottfries et al., 1996. Both of these previous studies showed a 
significant decrease in ST in AD. 
Han and colleagues showed a 60% decrease in WM using electrospray ionization 
mass spectrometry, which is a more sensitive method for quantitative analysis of Sulfatide 
than TLC. Although TLC is a less sensitive it is unlikely that the 60% decrease observed 
in the Han study would not have been detected. Gottfries et al., 1996, differentiated 
between early and late AD and compared them both to non-AD tissue in their study of 
brain lipids. They used TLC to analyze ST content in the late onset tissue and compared 
-this to the control, revealing nearly a 40% decrease. In the present study we did not 
differentiate between early and late onset AD, and herein may lay the reason for the 
conflicting data. 
Considering that we only studied white matter and Gottfries did as well, yet Han 
also saw a decrease in ST in GM, it is possible that the ST level decrease that is truly 
important in AD pathogenesis is that in GM. Since the hallmark pathologies of AD are 
associated with the neuron, it would very possible that a decrease in GM ST would have a 
direct role in AD. 
Caveats 
Differences in axon density, caliber, and orientation among samples were a concern 
due to lack of specific information on the location of harvest. This concern was essentially 
eliminated by standardization with axon density and qualitative analysis of axon girth. 
Variation in duration between time of death and time of harvesting was initially a concern 
since it might possibly be cause for tissue degradation due to lipidases. The white matter 
was largely in excellent condition suggesting that state of membrane organization revealed 
by the sodium channel data could be trusted. Due to the high water content in WM of live 
tissue and the inconsistency in post-mortem treatment of our tissue, there was a possibility 
that the dry weight of the tissue, and therefore total lipids, harvested varied among 
samples. In order to control for this a protein assay was performed. Standardization by 
protein mass did not significantly change the relative ST concentrations among sample 
groups suggesting that variations in water content was not a significant source of error. 
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